Efficacy and Safety of Asenapine in a Placebo- and Haloperidol-Controlled Trial in Patients With Acute Exacerbation of Schizophrenia

Cited by (125)

Items 101–125 of 125

1. Asenapine Once Daily Versus Twice Daily
   Xiaowei Sun, Robert M. Hamer, Joseph P. McEvoy · 2015 · The Journal of Clinical Psychiatry
2. Treatment by asenapine for 5weeks decreases weight and triglycerides levels of Wistar rats
   Rodrigo Bernini de Brito, Paulo César Ghedini · 2014 · Schizophrenia Research
3. Effect of Lurasidone on symptoms of schizophrenia in five-factor dimensional model: pooled analysis of two short-term, randomized, double-blind, placebo-controlled studies in patients from Russia and Ukraine
   Sergey N Mosolov, A V Malyutin, A. A. Pikalov · 2019 · S S Korsakov Journal of Neurology and Psychiatry
4. New Options for the Treatment of Schizophrenia: A Clinical Review of the Three Most Recent Antipsychotic Drugs
   Ana D. Stan, Carol A. Tamminga · 2014 · FOCUS The Journal of Lifelong Learning in Psychiatry
5. Psychopharmacological management of schizophrenia
   David Jonathan Castle, Nga Tran, Deirdre Alderton · 2012 · CRC Press eBooks
6. When managing antipsychotic-induced somnolence, consider using lower-risk agents and promoting good sleep hygiene
   Adis Medical Writers · 2017 · Drugs & Therapy Perspectives
7. Chapter 31. Ziprasidone and Asenapine
   John W. Newcomer, Jared Lipsey, Martin Strassnig, Leslie Citrome · 2024 · American Psychiatric Association Publishing eBooks
8. Clinical experience and perspectives of using asenapine in stopping acute endogenous psychosis
   Panteleeva Gp, Igor V. Oleichik, T. E. Novozhenova, А. В. Соколов · 2015 · S S Korsakov Journal of Neurology and Psychiatry
9. Schizophrenia
   S. Hossein Fatemi, Timothy D. Folsom · 2016 · Springer eBooks
10. Antipsychotika bei Bipolar-I-Störungen
    Georg Juckel · 2011 · Der Nervenarzt
11. Asenapine: A Novel Hope in the Treatment of Schizophrenia and Manic and Mixed Episodes of Bipolar I Disorder
    Mesut Çetin · 2013 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
12. Biological Perspectives: Update on Newer Antipsychotic Drugs: Are They Evidence Based?
    Norman L. Keltner, Randy L. Moore, Joan S. Grant · 2011 · Perspectives In Psychiatric Care
13. Saphris: Does a unique delivery system equal a unique drug?
    Kelly N. Gable · 2011 · Mental Health Clinician
14. Asenapina: una review sistematica sulle principali tematiche della pratica clinica Asenapine: a systematic review on the main topics of clinical practice
    Andreas Conca · 2013
15. Неудовлетворенные терапевтические потребности больных шизофренией: предоставляет ли асенапин дополнительные терапевтические возможности?
    Maurizio Pompili, Дж Серафини, Marco Innamorati, Э. Амбрози, Ludovica Telesforo, Paola Venturini, Г. Джиордано, Michele Battuello, David Lester, П. Джирарди · 2011 · Социальная и клиническая психиатрия
16. "Danger Will Robinson!" - Intra-Cellular Therapies Stock Soars While Key Clinical Data Not Presented to Shareholders Looks Highly Disappointing
    Published July · 2015
17. The Challenge of Adherence in Schizophrenia
    Fernando Cañas de Paz, José Manuel Olivares · 2013 · Evolving Medicine Ltd eBooks
18. New drugs: Ticagrelor
    2011 · Australian Prescriber
19. Current awareness: Pharmacoepidemiology and drug safety
    Ltd. © John Wiley Sons Usado con permiso de John Wiley . Sons · 2010 · Pharmacoepidemiology and Drug Safety
20. New drugs: Ipilimumab
    2011 · Australian Prescriber
21. New drugs: Fingolimod hydrochloride
    2011 · Australian Prescriber
22. New drugs: Apixaban
    2011 · Australian Prescriber
23. Mood Stabilizers: Asenapine
    Frank Martin Schmidt · 2022 · Springer eBooks
24. Mood Stabilizers: Asenapine
    Frank Martin Schmidt · 2022 · Springer eBooks
25. The effect of differences in trial design on estimates of efficacy of olanzapine in randomized studies
    Francesco Rotella, Andrea Falone, Emanuele Cassioli, Edoardo Mannucci, Valdo Ricca, Francesco Monaco · 2024 · Psychiatry Research